34 results on '"Gillan, Tanya L."'
Search Results
2. Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, Canada
3. Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada
4. Clonal evolution as detected by interphase fluorescence in situ hybridization is associated with worse overall survival in a population-based analysis of patients with chronic lymphocytic leukemia in British Columbia, Canada
5. Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization
6. Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort
7. An undiagnosed cytogenetic abnormality results in the misidentification of a Duchenne muscular dystrophy carrier
8. Costello syndrome associated with novel germline HRAS mutations: An attenuated phenotype?
9. Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada
10. Ultrasensitive Detection of NOTCH1c.7544_7545delCT Mutations in Chronic Lymphocytic Leukemia by Droplet Digital PCR Reveals High Frequency of Subclonal Mutations and Predicts Clinical Outcome in Cases with Trisomy 12
11. Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada.
12. Immunoglobulin heavy chain (IGH@) translocations negatively impact treatment-free survival for chronic lymphocytic leukemia patients who have an isolated deletion 13q abnormality
13. Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada
14. Identification of novel genes involved in the genesis of Wilms tumor of the kidney
15. Autoimmune Cytopenia in Chronic Lymphocytic Leukemia: Effect on Outcome and Survival, a Population Based Analysis in British Columbia, Canada
16. Clinical Outcomes for Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion in British Columbia (BC), Canada: Results of a Population-Based Cohort
17. Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database
18. Comparison of Outcomes in Chronic Lymphocytic Leukemia (CLL) with the Addition of Rituximab to Initial Treatment: A Comparative Effectiveness Analysis in the Province of British Columbia (BC), Canada
19. Comprehensive Assessment of Clinical Outcomes for CLL Patients with Trisomy 12 (+12): Results of a Population-Based Analysis of 822 CLL Patients in British Columbia (BC), Canada
20. Factors Predictive for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia in a Population-Based Provincial Transplant Cohort
21. Clonal Evolution Predicts Poor Prognosis in Chronic Lymphocytic Leukaemia and Is Possibly a Worse Prognostic Factor Than 17p Deletion: A Population Based Cohort study of FISH Testing in British Columbia, Canada
22. Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL
23. 3.11 Population-Based Analysis of Cytogenetic Abnormalities in Chronic Lymphocytic Leukemia (CLL): Provincial Laboratory Standardization and Prevalence of FISH Abnormalities in British Columbia (BC), Canada
24. Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Eradication of Specific FISH Abnormalities with Relation to Gvhd and Transplant Outcomes.
25. Impact of Immunoglobulin Heavy Chain (IGH) Translocations In Chronic Lymphocytic Leukemia (CLL): Negative Effect on Patients with Isolated Deletion 13q Abnormality
26. Costello syndrome associated with novel germlineHRAS mutations: An attenuated phenotype?
27. Cytogenetic and molecular characterization of a de-novo cryptic deletion of 7p21 associated with an apparently balanced translocation and complex craniosynostosis
28. Influence of Clone and Deletion Size on Outcome in Chronic Lymphocytic Leukemia Patients with an Isolated Deletion 13q in a Population-Based Analysis in British Columbia, Canada.
29. The Simpson–Golabi–Behmel gene, GPC3, is not involved in sporadic Wilms tumorigenesis
30. THE CHALCID SEED WASP, MEGASTIGMUS NIGROVARIEGATUS HYMENOPTERA: TORYMIDAE, ON ROSA RUGOSA THUNB. IN NOVA SCOTIA
31. Respiratory Syncytial Virus Triggers Synthesis of IL-6 in BALB/c Mouse Alveolar Macrophages in the Absence of Virus Replication
32. Limiting the Niemann-Pick Type C critical region to a 1-cM interval.
33. The SimpsonGolabiBehmel gene, <TOGGLE>GPC3</TOGGLE>, is not involved in sporadic Wilms tumorigenesis
34. THE CHALCID SEED WASP, MEGASTIGMUS NIGROVARIEGATUSHYMENOPTERA: TORYMIDAE, ON ROSA RUGOSATHUNB. IN NOVA SCOTIA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.